126 related articles for article (PubMed ID: 27529394)
1. The clinical spectrum of mycosis fungoides in Tanzania, East Africa.
Grijsen ML; Mtayangulwa RG; Naafs B; Jansen P; Vermeer MH; Mavura D; Masenga EJ; Willemze R
Br J Dermatol; 2017 Jun; 176(6):1653-1656. PubMed ID: 27529394
[No Abstract] [Full Text] [Related]
2. Tumour d'emblee.
Razmi T M; Handa S; Mahajan R; Saikia UN; Mittal BR
Lancet Oncol; 2017 Aug; 18(8):e503. PubMed ID: 28759389
[No Abstract] [Full Text] [Related]
3. [A case of mycosis fungoides with pulmonary involvement: effect of etoposide and prednisolone].
Nasuhara Y; Kobayashi S; Munakata M; Kawakami Y; Fujita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):1013-8. PubMed ID: 8538082
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue.
Schappell DL; Alper JC; McDonald CJ
Arch Dermatol; 1995 Mar; 131(3):307-13. PubMed ID: 7887660
[TBL] [Abstract][Full Text] [Related]
5. Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides.
MacArthur KM; Jariwala N; Kim EJ; Rook AH
Acta Derm Venereol; 2017 Mar; 97(3):373-374. PubMed ID: 27868149
[No Abstract] [Full Text] [Related]
6. Advanced Mycosis Fungoides.
Maredia H; Rozati S
N Engl J Med; 2020 Apr; 382(14):e27. PubMed ID: 32242361
[No Abstract] [Full Text] [Related]
7. [Epidemiological and clinical profile and outcome in 166 mycosis fungoides patients in Casablanca].
Erraji H; Hali F; Baline K; Marnissi F; Chiheb S
Ann Dermatol Venereol; 2019 Dec; 146(12):825-828. PubMed ID: 31519349
[No Abstract] [Full Text] [Related]
8. Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome.
Avilés A; Nambo MJ; Neri N; Castañeda C; Cleto S; Gonzalez M; Huerta-Guzmán J
Cancer Biother Radiopharm; 2007 Dec; 22(6):836-40. PubMed ID: 18158775
[TBL] [Abstract][Full Text] [Related]
9. Mycosis fungoides bullosa.
Natsuga K; Shimizu T; Abe R; Kodama K; Shimizu H
Arch Dermatol; 2006 Jun; 142(6):793-5. PubMed ID: 16785397
[No Abstract] [Full Text] [Related]
10. Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
de Quintana-Sancho A; Acebo-Mariñas E; Gardeazabal-García J; Aperribay-Esparza A
Actas Dermosifiliogr; 2015 Oct; 106(8):693-5. PubMed ID: 26071909
[No Abstract] [Full Text] [Related]
11. A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy.
Postorino M; Pupo L; Provenzano I; Del Principe MI; Buccisano F; Franceschini L; Rizzo M; Nasso D; Meconi F; Onnis I; Vaccarini S; Zizzari A; Anemona L; Mauramati S; Bruno E; Cantonetti M; Amadori S
Ann Hematol; 2016 Jan; 95(1):153-154. PubMed ID: 26442854
[No Abstract] [Full Text] [Related]
12. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
Heisig M; Maj J; Szepietowski JC; Reich A
Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
14. Advanced mycosis fungoides: chemotherapy with etoposide, methotrexate, bleomycin, and prednimustine.
Doberauer C; Ohl S
Acta Derm Venereol; 1989; 69(6):538-40. PubMed ID: 2481928
[TBL] [Abstract][Full Text] [Related]
15. Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.
Demierre MF; Vachon L; Ho V; Sutton L; Cato A; Leyland-Jones B
Arch Dermatol; 2003 May; 139(5):624-8. PubMed ID: 12756099
[TBL] [Abstract][Full Text] [Related]
16. Lymphomatoid papulosis terminating as cutaneous T cell lymphoma (mycosis fungoides).
Madison JF; O'Keefe TE; Meier FA; Clendenning WE
J Am Acad Dermatol; 1983 Nov; 9(5):743-7. PubMed ID: 6643771
[TBL] [Abstract][Full Text] [Related]
17. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients.
Zackheim HS; Kashani-Sabet M; McMillan A
J Am Acad Dermatol; 2003 Nov; 49(5):873-8. PubMed ID: 14576667
[TBL] [Abstract][Full Text] [Related]
18. Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients.
Sentis HJ; Willemze R; Van Vloten WA
Acta Derm Venereol; 1985; 65(2):179-83. PubMed ID: 2408428
[TBL] [Abstract][Full Text] [Related]
19. Mycosis Fungoides: Experience in a Pediatric Hospital.
Cervini AB; Torres-Huamani AN; Sanchez-La-Rosa C; Galluzzo L; Solernou V; Digiorge J; Rubio P
Actas Dermosifiliogr; 2017; 108(6):564-570. PubMed ID: 28279399
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of the combination of systemic gemcitabine and intralesional brentuximab vedotin in tumor-stage mycosis fungoides.
Torre-Castro J; Recio-Monescillo M; Castillo Bazan E; Díaz de la Pinta J; Rodríguez Pinilla M; Requena L; Córdoba R
Int J Dermatol; 2024 Jun; 63(6):828-830. PubMed ID: 38419393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
